Zhejiang Tailin Bioengineering Co Ltd Asset Resilience Ratio

Latest as of March 2026: 8.46%

Zhejiang Tailin Bioengineering Co Ltd asset resilience ratio. Zhejiang Tailin Bioengineering Co Ltd (300813) has an Asset Resilience Ratio of 8.46% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Zhejiang Tailin Bioengineering Co Ltd to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥80.10 Million

≈ $11.72 Million USD Cash + Short-term Investments

Total Assets

CN¥946.91 Million

≈ $138.56 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Zhejiang Tailin Bioengineering Co Ltd (2021–2025)

Asset resilience ratio of Zhejiang Tailin Bioengineering Co Ltd from 2021 to 2025. This chart shows how Zhejiang Tailin Bioengineering Co Ltd's Asset Resilience Ratio has changed over time. Read 300813 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Tailin Bioengineering Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Zhejiang Tailin Bioengineering Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥80.10 Million	8.46%
Total Liquid Assets	CN¥80.10 Million	8.46%

Asset Resilience Insights

Limited Liquidity: Zhejiang Tailin Bioengineering Co Ltd maintains only 8.46% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Tailin Bioengineering Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Tailin Bioengineering Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Demant A/S CO:DEMANT	Medical Devices	-2.59%
Shanghai Sanyou Medical Co Ltd SHG:688085	Medical Devices	7.69%
CareRay Digital Medical Technology Co Ltd SHG:688607	Medical Devices	16.21%
Cleo Diagnostics Ltd AU:COV	Medical Devices	94.64%
Memphasys Ltd AU:MEM	Medical Devices	0.00%
Cochlear Ltd AU:COH	Medical Devices	9.76%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%
Polynovo Ltd AU:PNV	Medical Devices	0.04%

Zhejiang Tailin Bioengineering Co Ltd Asset Resilience Ratio by Year (2021–2025)

Zhejiang Tailin Bioengineering Co Ltd asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for Zhejiang Tailin Bioengineering Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	19.13%	CN¥183.51 Million ≈ $26.85 Million	CN¥959.34 Million ≈ $140.38 Million	+16.07pp
2021-12-31	3.06%	CN¥20.05 Million ≈ $2.93 Million	CN¥655.87 Million ≈ $95.97 Million	--

pp = percentage points

About Zhejiang Tailin Bioengineering Co Ltd

SHE:300813 China Medical Devices

Market Cap

$331.83 Million

CN¥2.27 Billion CNY

Market Cap Rank

#14027 Global

#4170 in China

Share Price

CN¥18.71

Change (1 day)

-2.96%

52-Week Range

CN¥17.08 - CN¥30.88

All Time High

CN¥64.43